Summary
The metabolism of probenecid has been investigated in both normal and gouty subjects. To carry out these studies, specific spectrophotometric methods were developed for the measurement of a major metabolite of probenecid, the acyl glucuronide. This conjugate was isolated in semi-pure state and its identity as a mono acyl glucuronide established. Our experiments indicate that about 25% of probenecid is converted to its acyl glucuronide and that only a small amount of the drug is excreted unchanged. About 80% of orally administered14C probenecid could be accounted for in urine, and about half of this was found to consist of metabolites more polar than the parent drug. The renal clearance of probenecid acyl glucuronide was shown to be about 1/3 that of creatinine clearance, whereas the clearance of probenecid was lower. The present findings in man and those of other workers in animals, raise the important question of the possible contribution of these metabolites to the overall pharmacological effects resulting from the administration of probenecid.
Similar content being viewed by others
References
Bonsnes, R.W., Taussky, H.H.: On the colorimetric determination of creatinine by the Jaffe reaction. J. biol. Chem.158, 581–591 (1945).
Burns, J.J., Cucinell, S.A., Koster, R., Conney, A.H.: Application of drug metabolism to drug toxicity studies. Ann. N.Y. Acad. Sci.123, 273–286 (1965).
Dayton, P.G., Weiss, M.M., Perel, J.M.: The effect of probenecid, phenylbutazone and their analogues on the excretion of L-ascorbic acid in rats. J. med. Chem.9, 941–944 (1966).
Dayton, P.G., Cucinell, S.A., Weiss, M., Perel, J.M.: Dose-dependence of drug plasma level decline in dogs. J. Pharmacol. exp. Ther.158, 305–316 (1967).
Dayton, P.G., Yü, T.F., Chen, W., Berger, L., West, L.A., Gutman, A.B.: The physiological disposition of probenecid, including renal clearance, in man, studied by an improved method for its estimation in biological material. J. Pharmacol. exp. Ther.140, 278–286 (1963).
Dunagin, Jr., P.E., Zachman, R.D., Olson, J.A.: The identification of metabolites of retinal and retinoic acid in rat bile. Biochim. biophys. Acta124, 71–85 (1966).
Guarino, A.M., Schanker, L.S.: Biliary excretion of probenecid and its glucuronide. J. Pharmacol. exp. Ther.164, 387–395 (1968).
Guarino, A.M., Conway, W.D., Fales, H.M.: Mass spectral identification of probenecid metabolites in rat bile. Europ. J. Pharmacol.8, 244–252 (1969).
Harman, R.E., Meisinger, M.A.P., Davis, G.E., Kuehl, Jr., F.A.: The metabolites of indomethacin, a new anti-inflammatory drug. J. Pharmacol. exp. Ther.143, 215–220 (1964).
Harman, R.E., Kuehl, Jr., F.A., Strachan, R.G., Hirschmann, R.F.: Indomethacin anti-inflammatory drug. Belg. 650, 447 Jan. 11, 1965; Chem. Abstr. 63:P, 1126 3h (1965).
Hauser, C.R., Renfrow, Jr., W.B.: Benzohydroxamic acid. Org. Synth.19, 15–17 (1939).
Lipmann, F., Tuttle, L.C.: A specific micro-method for the determination of acyl phosphates. J. biol. Chem.159, 21–28 (1945).
Maughan, G.B., Evelyn, K.A., Browne, J.S.L.: A method for the quantitative estimation of glucuronic acid and conjugated glucuronides. J. biol. Chem.126, 567–572 (1938).
Nery, R.: The colorimetric determination of hydroxamic acids. The Analyst91, 388–394 (1966).
Neff, N.H., Tozer, T.N., Brodie, B.B.: Application of steady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. J. Pharmacol. exp. Ther.158, 213–218 (1967).
Perel, J.M., Cunningham, R.F., Fales, H.M., Dayton, P.G.: Identification and renal excretion of probenecid metabolites in man. Life Sci.9, 1337–1343 (1970).
Perel, J.M., Dayton, P.G., Snell, M.McM., Yü, T.F., Gutman, A.B.: Studies of interactions among drugs in man at the renal level: probenecid and sulfinpyrazone. Clin. pharmacol. Ther.10, 834–840 (1969).
Quick, A.J.: The preparation and study of β, d-glycuronic acid monobenzoate (benzoyl glycuronic acid). J. biol. Chem.69, 549–563 (1926).
Roos, B.E., Sjöström, R.: 5-hydroxyindoleacetic acid (and homovanillic acid) levels in the cerebrospinal fluid after probenecid application in patients with manic-depressive psychosis. Pharmacol. Clin.1, 153–155 (1969).
Schachter, D.: The chemical estimation of acyl glucuronides and its application to studies on the metabolism of benzoate and salicylate in man. J. clin. Invest.36, 297–302 (1957).
Schachter, D., Manis, J.G.: Salicylate and salicyl conjugates: fluorimetric estimation, biosynthesis and renal excretion in man. J. clin. Invest.37, 800–807 (1958).
Shore, P.A., Brodie, B.B., Hogben, C.A.M.: The gastric secretion of drugs: a pH partition hypothesis. J. Pharmacol. exp. Ther.119, 361–369 (1957).
Skerith, M.D., Simkin, P.A., Healey, L.A.: The renal excretion of indomethacin and its inhibition by probenecid. Clin. Pharmacol. Ther.9, 89–93 (1968).
Stone, S.L.: The effect of benemid on the hepatic extraction and biliary excretion of bromsulphalein. Liver Function, Ed. by R.W. Brauer, publication No. 4, 298–301, Amer. Inst. of Biol. Sci., Washington, D. C. 1958.
Tillson, E.K., Schuchardts, G.S., Fishman, J.K., Beyer, K.H.: The determination of probenecid (Benemid) in body fluids. J. Pharmacol. exp. Ther.11, 385–394 (1954).
Tsukamoto, H., Kato, K., Yoshida, K.: Metabolism of drugs XL11. Isolation of ester glucuronides of Pamino salicylic acid and salicylic acid from the urine of rabbits. Chem. Pharm. Bull. Tokyo Bull12, 731–734 (1964).
Yü, T.F., Dayton, P.G., Gutman, A.B.: Mutual suppression of the uricosuric effects of sulfinpyrazone and salicylate: a study in interactions between drugs. J. clin. Invest.42, 1330–1339 (1963).
Weiner, I.M., Mudge, G.H.: Renal tubular mechanisms for excretion of organic acids and bases. Amer. J. Med.36, 743–762 (1964).
Williams, R.T.: Detoxication mechanisms. New York: John Wiley and Sons, 2nd Edition (1959).
Wiseman, E.H., Schreiber, E.C., Pinson, Jr., R.: Studies of N-dealkylation of some aromatic sulfonamides. Biochem. Pharmacol.11, 881–884 (1962).
Author information
Authors and Affiliations
Additional information
Supported by NIH Grants A-162 and GM-14270; portions of this work were initially carried out under Grant A-4724 at the NYU Research Service, Goldwater Memorial Hospital, New York, N.Y.
Rights and permissions
About this article
Cite this article
Perel, J.M., Dayton, P.G., Yü, T.F. et al. Studies of the renal excretion of probenecid acyl glucuronide in man. Eur J Clin Pharmacol 3, 106–112 (1971). https://doi.org/10.1007/BF00619303
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00619303